Capricor Therapeutics, Inc. (CAPR) stock
CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$8.03−0.38 (-4.52%)
Close on Nov 18, 2026Market cap $466.86MP/E –Yield –
Capricor Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Capricor Therapeutics's total debt was $0 at Dec 31, 2021. For fiscal 2021 it was $0, down 100.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $71.47K | – |
| FY2019 | Dec 31, 2019 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $0 | -100.0% |
| Q1 FY2021 | Mar 31, 2021 | $35.47K | – |
| Q4 FY2020 | Dec 31, 2020 | $71.47K | – |
| Q3 FY2020 | Sep 30, 2020 | $124.92K | – |
| Q2 FY2020 | Jun 30, 2020 | $178.23K | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
See a number that looks wrong?